April – June quarter sales up
10%, earnings per share up 12%
CINCINNATI , Aug. 1, 2005 – The Procter & Gamble
Company (NYSE:PG) announced strong top- and bottom-line growth
for the April – June quarter and the fiscal year. The company
posted net sales growth of
10 percent for both the quarter and fiscal year. Diluted net
earnings per share were $0.56 for the quarter, a 12 percent
increase, and $2.66 for the fiscal year, a 15 percent increase.
This is the fourth consecutive fiscal year the company delivered
results at or above its long-term annual growth rate targets
for sales, earnings per share and free cash flow productivity.
Executive Summary
- Unit volume grew six
percent for the quarter
and eight percent for the
fiscal year. Organic volume,
which excludes the impact
of acquisitions and divestitures,
increased seven percent
for the quarter and eight
percent for the fiscal
year. All business segments,
regions and each of the
company’s top 16 brands
posted volume growth for
the fiscal year.
-
Net sales for the quarter
increased 10 percent to
$14.26 billion. For the
fiscal year, sales also
grew 10 percent to $56.74
billion. Organic sales,
which exclude the impacts
of acquisitions, divestitures
and foreign exchange, grew
nine percent for the quarter
and eight percent for fiscal
year.
- Diluted net earnings
per share increased
12 percent for
the quarter and
15 percent for
the fiscal year.
- Earnings for
both periods improved
behind top-line
growth, the benefits
of a balanced portfolio
and a strong innovation
program, despite
a challenging cost
and competitive environment.
“We delivered another year of strong top- and bottom-line
results despite significant
challenges from higher commodity costs, increased competitive
spending and continued economic weakness in Western Europe and
Japan,” said Chairman of the Board, President and Chief Executive
A.G. Lafley. “Our balanced brand, customer and geographic presence
and focus on consumer value and innovation leadership continue
to drive P&G’s
sustained growth. Today, P&G is well positioned to deliver
its growth targets, and the
combination with Gillette will provide further upside over
the mid- and long-term.”
April – June Quarter Discussion
Unit volume for the April – June quarter increased six percent.
Organic volume grew seven percent, which excludes the impact
of acquisitions and divestitures from year-over-year comparisons
– primarily the divestiture of the juice business. Volume
growth was broad-based, led by strong gains in beauty, fabric,
health and home care. All regions posted unit volume growth
of mid-single digits or better, led by developing markets
with growth in the mid-teens.
Net sales for the quarter increased 10 percent
to $14.26 billion. Organic sales increased nine percent, well
above the company’s long-term annual target. Foreign exchange
added two percent to sales growth due to the strength of the
euro, Canadian dollar and British pound. Pricing added two
percent to sales growth behind actions that partially recovered
the impact of higher commodity costs in family care, pet health & nutrition,
coffee and certain fabric
care markets.
For the quarter, net earnings increased nine percent to
$1.50 billion. Earnings growth was primarily driven by volume
and pricing, partially offset by higher commodity costs. Diluted
net earnings per share increased 12 percent to $0.56. Diluted
net earnings per share grew ahead of net earnings due to share
repurchase activity. The company’s stepped up share repurchase
activity associated with the Gillette acquisition, net of
interest expense, was neutral to earnings per share on the
quarter.
Key Financial Highlights for the Quarter
- Gross margin contracted
110 basis points versus
the prior year. Gross margin
decreased due to higher
commodity costs, the mix
impact of strong growth
in developing markets and
the higher royalty expense
rate for Prilosec OTC®.
These more than offset
the impacts of price increases,
the scale benefits of volume
and manufacturing cost
savings.
- For the quarter,
selling, general and
administrative expenses
(SG&A) as
a percent of net sales
improved by 70 basis points.
Advertising spending was
up, but decreased as a
percent of sales behind
scale leverage. This was
partially offset by investments
in selling capability,
primarily in P&G
Beauty.
Business Segment Discussion for the Quarter
The following provides perspective on the company’s April
– June quarter results by business segment.
-
P&G Beauty
For the quarter,
P&G
Beauty delivered strong
sales and double-digit
earnings growth. Unit
volume increased eight
percent behind broad-based
growth, including strong
double-digit growth
of the Olay® brand
and developing markets.
Global feminine care
volume increased by
low-double digits behind
product innovations
on Always/Whisper®
and continued growth
of Naturella®. Professional
and Prestige grew low-double
digits behind strong
results in the Professional
business. Global hair
care volume increased
high-single digits
behind the continued
growth of Pantene®,
Head & Shoulders®
and Rejoice®. P&G
Beauty net sales
increased 12 percent
to $4.93 billion,
including a three
percent gain from
foreign exchange.
Net earnings increased
27 percent to $644
million primarily
due to volume growth
and cost savings
projects.
- P&G Family
Health
Health care
delivered a
very strong
quarter
of volume,
sales and earnings
growth. Unit
volume increased
12 percent
behind the
continued success
of Prilosec
OTC, Actonel® and
oral care in developing
markets. Health
care net sales
increased 16
percent to
$1.90 billion,
including
a positive
foreign exchange
impact of two percent.
Pricing added
two percent
to sales growth
due to actions
taken earlier in
the year in pet
health & nutrition
and
pharmaceuticals.
Net
earnings increased
42 percent to
$182 million
driven by volume,
partially offset
by the higher
royalty expense
rate for Prilosec
OTC. Earnings
margin also
increased due
to lower marketing
spending as
a percentage
of sales.
- For the quarter,
baby care and
family care delivered
strong sales
and earnings
growth. Unit
volume increased
six percent behind
the continued success
of Baby Stages of Development®
and recent initiatives
on Charmin® and Bounty®
in North America
. Net sales increased
10 percent to
$3.01 billion,
with foreign exchange
contributing two percent
to sales growth. Pricing
added two percent to
sales growth primarily
from actions earlier
in the fiscal year
in family care
to recover higher
commodity costs.
Earnings grew 25 percent
to $246 million. Earnings
increased behind the
scale benefits of volume
growth and manufacturing
cost savings. Pricing
largely offset the
negative impact
of higher commodity
costs and initiatives.
-
P&G Household Care
Fabric care and home
care unit volume increased
eight percent in the
April – June quarter. Developing
market volume increased
by mid-teens behind
the continued growth of Tide®
and Ariel®. Growth
was also driven by initiatives
-- Swiffer® in Western
Europe; Ariel Ion Power
Gel® in North East
Asia; Tide with a Touch of
Downy®, Febreze Air Effects®
and Dawn® in North America.
Net sales increased
10 percent to $3.85 billion,
including a positive
foreign exchange impact of
two percent. Pricing actions
on select brands in
the United States , Latin
America , Eastern Europe ,
China and certain Western
European countries added one
percent to sales growth.
The mix effect of strong developing
market growth reduced
sales by one percent. Net
earnings were $458 million,
a decrease of 11 percent.
Earnings margin declined primarily
due to commodity costs,
which continued to
increase in the quarter.
- For the quarter, snacks
and coffee delivered
strong earnings growth.
Unit volume was flat.
Net sales increased 11
percent to $787 million
propelled by pricing
in coffee to recover
the impact of higher
commodity costs. Positive
foreign exchange of one
percent was offset by
product mix. Net earnings
were $105 million,
an increase of 62 percent.
Earnings increased due
to sales growth and continued
progress on cost savings
against a base period
where coffee market pricing
lagged commodity cost
increases.
Fiscal Year Discussion
For the fiscal year, the company delivered results at or
above its long-term annual growth targets for sales, earnings
per share and free cash flow productivity. Unit volume for
the fiscal year increased eight percent. Organic volume also
grew eight percent. Volume growth was broad-based, reflecting
the overall balance of the company’s portfolio, with double-digit
growth from the beauty and health care businesses. All regions
delivered mid-single digit volume growth or better, with developing
market volume growth in the high-teens. Every one of the company’s
top 16 brands and each of the top 16 countries delivered volume
growth for the fiscal year.
Net sales for the fiscal year reached a record
level of $56.74 billion,
an increase of 10 percent
versus the prior year. Foreign exchange contributed two percent
to net sales growth, primarily driven by the strength of the
euro, British pound and Japanese yen. Net sales excluding
foreign exchange increased eight percent, above the company’s
long-term target of four to six percent. Organic sales, which
exclude the effects of acquisitions, divestitures and foreign
exchange, also increased eight percent. Mix reduced sales
by one percent due to higher relative growth in developing
markets. Pricing added one percent to sales growth behind
actions to recover higher commodity costs in family care,
pet health & nutrition, coffee and
in certain fabric care markets.
These actions were partially
offset by price investments
taken primarily earlier in the fiscal year to address the
growth of hard discounters in Europe and in response to competitive
activity in select fabric care and baby care markets.
Net earnings in 2005 increased 12 percent to
$7.26 billion. Net earnings margin increased 20 basis points
to 12.8 percent. Earnings margin grew primarily behind volume
and cost reduction efforts, which more than offset the effects
of higher commodity costs.
Diluted net earnings per share were $2.66, an increase of
15 percent compared to the prior year and above the company’s
annual minimum target growth rate of 10 percent. Diluted net
earnings per share grew ahead of net earnings due to the company’s
share repurchase activity.
The effective tax rate for the fiscal year improved
by 20 basis points compared
to the prior year. This includes
a provision of $295 million
for taxes on the anticipated repatriation of income earned
outside of the United States under the American Jobs Creation
Act. The company plans to repatriate $7.20 billion under the
Act. This charge was largely offset by the reversal of tax
provisions for the successful resolution of tax audits in
certain countries. The effective tax rate also benefited from
the overall country mix of taxable income.
Key Financial Highlights for the Fiscal Year
-
Gross margin in 2005
was 51.0 percent, a decrease
of 20 basis points versus
the prior year. The company
was able to largely offset
higher commodity costs,
which reduced gross margin
by more than 100 basis
points, through the scale
benefits of volume growth,
supply chain savings and
pricing. Gross margin also
contracted due to the mix
impact of strong growth
in developing markets.
- G&A as a percent
of sales improved by
40 basis points in 2005
versus the prior year.
Lower marketing spending
as a percent of net sales
drove the basis point
reduction in SG&A.
Absolute spending for
marketing increased
behind higher television
advertising and production
expense, as well as
increased promotional
activity in response
to competition. Marketing
spending increased
to support product
innovations including
Olay Anti-Aging ® ,
Olay Moisturinse ®
, Olay Quench ® , Pantene
Pro-Health ® , Pantene
Color Expressions ®
, Tide with a Touch
of Downy ® , Tide Coldwater
® , Febreze Air Effects
® , Pampers Feel n’
Learn ® , Kandoo Toddler
Wipes and Handsoap
® , and the geographical
expansion of SK-II
® , Lenor ® and Herbal
Essences ® . Overhead
spending as a percentage
of net sales was consistent
with the prior year
period. Scale efficiencies
in the base business
were offset by the
mix impact of two additional
months of Wella in
the current year and
investments in selling
capability. Minority
interest expense decreased
versus the base period
reflecting the impacts
from the company’s
purchase of the remaining
stake in its China
venture from Hutchison
Whampoa China Ltd.,
as well as the completion
of the domination and
profit transfer agreement
with Wella AG.
-
The company’s operating
cash flow for the fiscal
year was $8.72 billion
compared to $9.36 billion
in the prior year.
The operating cash increase
from higher net earnings
was offset primarily
by changes in inventory
and payables. Inventory
days on hand were up
two days versus the prior
year due to higher commodity
costs and efforts to
rebuild inventory levels
in product categories
that could not meet customer
demand. Days payables
were down three days
versus the prior year.
Operating cash was
also reduced by tax payments
related to the settlement
of prior year audits.
Capital expenditures
for he year were 3.8
percent of net sales,
slightly below the company’s
long-term target of about
4 percent of net sales.
Free cash flow, defined
as cash from operating
activities less capital
expenditures was $6.54
billion. This represents
free cash flow productivity
of 90 percent, in-line
with the company’s
long-term objective.
Fiscal Year Business Segment Discussion
The following provides perspective on the company’s fiscal
year results by business segment.
P&G Beauty
- P&G Beauty delivered
outstanding results with
double-digit sales and
earnings growth for the
fiscal year. Unit volume
increased 12 percent. Organic
volume increased eight
percent, with the difference
due primarily to the full
year impact of Wella. Unit
volume increased behind
base business growth and
several new product initiatives
including Olay Quench hand
and body lotions, Olay
Moisturinse in-shower body
moisturizer, Lacoste Touch
of Pink ® , Pantene Pro-Health
and Pantene Color Expressions.
Double-digit growth in
the feminine care business
continues to be driven
by product upgrades to
the Always/Whisper brands
and the successful introduction
of Naturella in Latin America
and Central and Eastern
Europe . Global hair care
increased by low-double
digits behind the Pantene,
Head & Shoulders,
Herbal Essences, Rejoice
and Aussie ® brands.
Net sales increased
14 percent to $19.48
billion. Foreign exchange
contributed three percent
to sales growth, while
the mix impact of strong
sales in developing
markets reduced sales
by one percent. Net
earnings increased
22 percent to $2.85
billion due to volume
growth, cost reduction
programs and the impacts
of the company’s increased
ownership of the China
operation and the domination
and profit transfer
agreement with Wella
AG. These benefits
were partially offset
by marketing spending
to support initiatives.
P&G Family Health
- Health care delivered
solid results for
the fiscal year. Unit
volume in 2005 increased
10 percent behind very
strong growth of Prilosec
OTC, Actonel and
oral care in developing
markets. Oral care
posted mid-single digit
volume growth globally
despite a challenging
competitive environment
in dentifrice and a
smaller market for
tooth whitening products.
Net sales increased
11 percent to $7.79
billion aided by a
positive two percent
foreign exchange impact.
Pricing in pet health & nutrition
and pharmaceuticals
increased sales by
one percent. Product
mix reduced sales
by two percent due
to strong oral care
growth in developing
markets and the shift
of branded Macrobid®
sales to generics.
Health care’s net earnings
were $1.00 billion,
an increase of eight
percent against a base
period comparison where
earnings increased
36 percent. Earnings
increased primarily
due to volume growth,
partially offset by
marketing investments
in support of initiatives.
After-tax earnings
margin declined 40
basis points year-over-year
due, in part, to product
mix impacts of lower
volume in branded Macrobid
and Crest Whitestrips®,
both of which have
higher margins than
the balance of the
health care business.
Earnings were also
negatively impacted
by a higher royalty
expense rate for
Prilosec OTC and higher
commodity costs.
-
For the fiscal year,
baby care and family care
delivered very strong results.
Unit volume increased seven
percent led by baby care’s
continued stream of innovation
including Feel ‘n Learn
training pants in North
America , Baby Dry ® fit
upgrade and Baby Stages
of Development upgrades
in Western Europe , and
the expansion of Pampers
Kandoo ® in North America
. Family care volume increased
due to product, packaging
and format initiatives
in North America on both
the Bounty and Charmin
brands. Net sales increased
11 percent to $11.89 billion,
including a positive three
percent impact from foreign
exchange. Pricing added
one percent to sales growth.
Actions in North America
family care to recover
higher commodity costs
were partially offset by
targeted pricing investments
in Western Europe baby
care in response to competitive
activity. Net earnings
increased 28 percent to
$1.26 billion, behind volume
and manufacturing cost
savings, partially offset
by marketing investments
in support of initiatives.
- Fiscal year unit volume
increased by nine
percent in fabric
care and home care. Acquisitions
in Europe and Latin
America contributed two percent to
volume growth versus
the prior year. Unit volume increased
behind strong initiative
activity, expansion of the
portfolio to serve
more consumers and continued growth
in developing markets.
Volume growth was led
by the continued
success of Lenor, Febreze Air Effects, Swiffer
Duster ® and Gain®
, as well as the launches of
Tide with a Touch
of Downy, Downy Simple Pleasures
and Mr. Clean Magic
Reach® . Developing markets grew volume
by double-digits,
led by Greater China and the continued
success of Tide.
Net sales increased
10 percent to $15.26 billion.
Foreign exchange
added two percent to sales growth.
The mix impact
of higher relative growth in developing
markets reduced
sales by one percent. Net earnings were
$2.13 billion,
a decrease of two percent compared
to the prior year.
After-tax earnings margins
declined primarily
due to higher commodity costs,
which more than
offset the scale benefits of volume
growth and pricing
actions taken during the year.
The after-tax margin
in 2005 was also negatively impacted
by the mix effect
of developing market growth.
- For the fiscal year,
snacks and coffee
delivered strong results. Unit
volume increased three
percent compared to
the prior year. Pringles
volume grew behind
expanded distribution and merchandizing
of customized flavors
and Pringles Prints
® in North America . Coffee
volume increased
behind Folgers ® dark roasts.
Net sales increased
eight percent to $3.14
billion. The combination
of pricing to recover
higher commodity costs
and reduced promotional
spending increased
sales four percent.
Foreign exchange had a positive
two percent effect
on sales growth. Net earnings
increased 21 percent
to $417 million behind
higher volume, pricing
to recover commodity
costs and lower merchandising
spending versus the
prior year.
Fiscal Year 2006 and July – September Quarter Guidance
Effective July 1, the company adopted stock option expensing
using the modified retrospective methodology. Prior year results
will be restated to reflect stock option expensing, consistent
with the pro forma disclosures in the Notes to Consolidated
Financial Statements. A summary of the pro forma stock option
expense for fiscal year 2005 appears at the end of this release.
Fiscal year guidance does not include any impacts
related to the pending acquisition of Gillette or the stepped
up share repurchase program. For 2006, the company expects
to deliver its fifth consecutive year of growth at or above
long-term targets, despite a very strong base period. Organic
sales are expected to grow by four to six percent. Foreign
exchange is expected to reduce sales by one to two percent.
The impact of acquisitions and divestitures is expected to
be neutral to sales growth, excluding Gillette. The combination
of pricing and product mix is expected to provide a modest
gain to sales growth. Total sales are expected to increase
hree to five percent. The company stated it is comfortable
with the current analysts’ consensus estimate of earnings
per share. This estimate excludes stock option expenses, which
the company expects will be $0.13 per share. The implied earnings
per share growth rate is in line with our double-digit long-term
target. Operating margins are expected to be up modestly.
The tax rate for fiscal year 2006 is expected to decline 25
to 75 basis points to about 30 percent, due mainly to strong
growth in lower tax rate regions.
Guidance for the July – September quarter includes the impact
of the company’s stepped up share repurchase program due to
the Gillette acquisition. For the quarter, the company expects
sales growth of six to eight percent. A modest gain from foreign
exchange is expected to be offset by the impact of the juice
divestiture in the prior year. The combination of pricing
and mix is expected to add one to two percent to sales growth.
The company is comfortable with the current analysts’ consensus
estimate of earnings per share, which excludes the impacts
of stock option expensing and stepped up share repurchases.
This is equivalent to earnings per share growth of 10 percent
excluding the $0.02 per share gain from the juice divestiture
proceeds in the base. Stock option expense for the quarter
should be $0.03 per share – in-line with prior year pro forma
results. The increase in year-on-year share repurchases, net
of associated interest expense, is expected to add up to $0.01
per share. Operating margin is expected to be about neutral
versus the comparable prior year period. The tax rate for
the quarter is expected to be about 30 percent.
Forward-Looking Statements
All statements, other than statements of historical
fact included in this release,
are forward-looking statements,
as that term is defined in the Private Securities Litigation
Reform Act of 1995. In addition
to the risks and uncertainties noted in this release, there
are certain factors that could cause actual results to differ
materially from those anticipated by some of the statements
made. These include: (1) the ability to achieve business plans,
including with respect to lower income consumers and growing
existing sales and volume profitably despite high levels of
competitive activity, especially with respect to the product
categories and geographical markets (including developing
markets) in which the company has chosen to focus; (2) the
ability to successfully execute, manage and integrate key
acquisitions and mergers, including (i) the Domination and
Profit Transfer Agreement with Wella, and (ii) the company’s
agreement to merge with The Gillette Company, including obtaining
the related required regulatory approvals; (3) the ability
to manage and maintain key customer relationships; (4) the
ability to maintain key manufacturing and supply sources (including
sole supplier and plant manufacturing sources); (5) the ability
to successfully manage regulatory, tax and legal matters (including
product liability, patent, and other intellectual property
matters), and to resolve pending matters within current estimates;
(6) the ability to successfully implement, achieve and sustain
cost improvement plans in manufacturing and overhead areas,
including the company's outsourcing projects; (7) the ability
to successfully manage currency (including currency issues
in volatile countries), debt (including debt related to the
company’s announced plan to repurchase shares of the company’s
stock), interest rate and certain commodity cost exposures;
(8) the ability to manage the continued global political and/or
economic uncertainty and disruptions, especially in the company's
significant geographical markets, as well as any political
and/or economic uncertainty and disruptions due to terrorist
activities; (9) the ability to successfully manage the pattern
of sales, including the variation in sales volume within periods;
(10) the ability to successfully manage competitive factors,
including prices, promotional incentives and trade terms for
products; (11) the ability to obtain patents and respond to
technological advances attained by competitors and patents
granted to competitors; (12) the ability to successfully manage
increases in the prices of raw materials used to make the
company's products; (13) the ability to stay close to consumers
in an era of increased media fragmentation; and (14) the ability
to stay on the leading edge of innovation. For additional
information concerning factors that could cause actual results
to materially differ from those projected herein, please refer
to our mostrecent 10-K, 10-Q and 8-K reports.
About
Procter & Gamble
Two billion times a day, P&G brands touch the lives
of people around the world. The company has one of the strongest
portfolios of trusted, quality, leadership brands, including
Pampers®, Tide®, Ariel®, Always®, Whisper®, Pantene®, Bounty®,
Pringles®, Folgers®, Charmin®, Downy®, Lenor®, Iams®, Crest®,
Actonel®, Olay®, Clairol Nice ‘n Easy®, Head & Shoulders®,
and Wella. The P&G community consists of almost 110,000
employees working in over
80 countries worldwide.
# # #
P&G Media Contact :
In
the US : 1-866-PROCTER or
1-866-776-2837
International:
+1 513 945 9087
P&G Investor
Relations Contact :
Thomas
Tippl: + 1 513 983 2414
The Procter & Gamble Company
Segment Names
Beginning
July 1, 2005 , we renamed our global business units. Beauty
Care was renamed P&G Beauty; Health, Baby
and Family Care was changed
to P&G Family Health; and
Household Care was renamed
P&G Household Care. No changes
were made to the composition
or historical results of the global business units.
Pro Forma Stock-Based Compensation
The company’s
guidance for fiscal year 2006 and the July – September quarter
includes the impacts of stock option expensing. In December
2004, the Financial Accounting Standards Board (FASB) issued
SFAS No. 123 (Revised 2004), “Share-Based Payment” (SFAS
123(R)). This Statement revises SFAS No. 123 by eliminating
the option to account for employee stock options under APB
No. 25 and generally requires companies to recognize the
cost of employee services received in exchange for awards
of equity instruments based on the grant-date fair value
of those awards (the “fair-value-based” method). The company
adopted SFAS 123(R) on July 1, 2005 using the modified retrospective
method, whereby all prior periods will be adjusted to give
effect to the fair-value-based method of accounting for awards
granted in fiscal years beginning on or after July 1, 1995
. The following table provides the pro forma stock-based
compensation expense for fiscal year 2005:
|
Q1 |
Q2 |
Q3 |
Q4 |
Fiscal
2005 |
Net
Earnings ($MM) |
|
|
|
|
|
As
Reported |
$2,001 |
$2,039 |
$1,720 |
$1,497 |
$7,257 |
Pro
Forma Expense |
59 |
64 |
106 |
105 |
334 |
Pro
Forma |
$1,942 |
$1,975 |
$1,614 |
$1,392 |
$6,923 |
|
|
|
|
|
|
Diluted
Net Earnings Per
Common Share |
|
|
|
|
|
As
Reported |
$0.73 |
$0.74 |
$0.63 |
$0.56 |
$2.66 |
Pro
Forma Expense |
($0.03) |
($0.02) |
($0.04) |
($0.04) |
($0.13) |
Pro
Forma |
$0.70 |
$0.72 |
$0.59 |
$0.52 |
$2.53 |
Measures Not Defined By U.S. GAAP
In
accordance with the SEC’s Regulation G, the following provides
definitions of measures used in the earnings release that
are not defined by accounting principles generally accepted
in the United States (U.S. GAAP) and the reconciliation to
the most closely related GAAP measure.
Organic sales growth is a non-GAAP measure of reported
sales growth excluding the impacts of acquisitions, divestitures
and foreign exchange from year-over-year comparisons. The
company believes this provides investors with a more complete
understanding of underlying results and trends of the base
businesses by providing sales on a consistent basis. The
reconciliation of reported sales growth to organic sales
growth for the quarter and year:
| |
Q4 |
FY2005 |
| Total Sales Growth |
10% |
10% |
| Less: Foreign Exchange
Impact |
2% |
2% |
| Less: Acquisitions/Divestitures |
-1% |
0% |
| Organic Sales Growth |
9% |
8% |
The company also reports free cash flow. Free cash flow
is defined as cash from operating activities less capital
expenditures. The company views free cash flow as an important
indicator of the cash available for dividends and discretionary
investment. Free cash flow is also one of the measures
used to evaluate management and is a factor in determining
at-risk compensation levels. Free cash flow productivity
is defined as the ratio of free cash flow to net earnings,
and is another measure used to evaluate management’s performance.
The company’s target for free cash flow productivity is
90 percent. The reconciliation of free cash flow and free
cash flow productivity is provided below:
| $MM |
Operating Cash Flow |
Capital Spending |
Free Cash Flow |
Net Earnings |
Free Cash Flow Productivity |
| Jul-Sept 03 |
1,606 |
364 |
1,242 |
1,761 |
71% |
| Oct-Dec 03 |
2,355 |
446 |
1,909 |
1,818 |
105% |
| Jan-Mar 04 |
2,978 |
521 |
2,457 |
1,528 |
161% |
| Apr-Jun 04 |
2,423 |
693 |
1,730 |
1,374 |
126% |
| Jul-Jun 04 |
9,362 |
2,024 |
7,338 |
6,481 |
113% |
| |
|